title: Characterization of H7N9 influenza A viruses isolated from humans.
abstract: Avian influenza A viruses rarely infect humans; however, when human infection and subsequent human-to-human transmission occurs, worldwide outbreaks (pandemics) can result. The recent sporadic infections of humans in China with a previously unrecognized avian influenza A virus of the H7N9 subtype (A(H7N9)) have caused concern owing to the appreciable case fatality rate associated with these infections (more than 25%), potential instances of human-to-human transmission, and the lack of pre-existing immunity among humans to viruses of this subtype. Here we characterize two early human A(H7N9) isolates, A/Anhui/1/2013 (H7N9) and A/Shanghai/1/2013 (H7N9); hereafter referred to as Anhui/1 and Shanghai/1, respectively. In mice, Anhui/1 and Shanghai/1 were more pathogenic than a control avian H7N9 virus (A/duck/Gunma/466/2011 (H7N9); Dk/GM466) and a representative pandemic 2009 H1N1 virus (A/California/4/2009 (H1N1pdm09); CA04). Anhui/1, Shanghai/1 and Dk/GM466 replicated well in the nasal turbinates of ferrets. In nonhuman primates, Anhui/1 and Dk/GM466 replicated efficiently in the upper and lower respiratory tracts, whereas the replicative ability of conventional human influenza viruses is typically restricted to the upper respiratory tract of infected primates. By contrast, Anhui/1 did not replicate well in miniature pigs after intranasal inoculation. Critically, Anhui/1 transmitted through respiratory droplets in one of three pairs of ferrets. Glycan arrays showed that Anhui/1, Shanghai/1 and A/Hangzhou/1/2013 (H7N9) (a third human A(H7N9) virus tested in this assay) bind to human virus-type receptors, a property that may be critical for virus transmissibility in ferrets. Anhui/1 was found to be less sensitive in mice to neuraminidase inhibitors than a pandemic H1N1 2009 virus, although both viruses were equally susceptible to an experimental antiviral polymerase inhibitor. The robust replicative ability in mice, ferrets and nonhuman primates and the limited transmissibility in ferrets of Anhui/1 suggest that A(H7N9) viruses have pandemic potential.
authors.affiliation: ERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama 332-0012, Japan.
authors.forename: Tokiko
authors.initials: T
authors.lastname: Watanabe
authors.forename: Maki
authors.initials: M
authors.lastname: Kiso
authors.forename: Satoshi
authors.initials: S
authors.lastname: Fukuyama
authors.forename: Noriko
authors.initials: N
authors.lastname: Nakajima
authors.forename: Masaki
authors.initials: M
authors.lastname: Imai
authors.forename: Shinya
authors.initials: S
authors.lastname: Yamada
authors.forename: Shin
authors.initials: S
authors.lastname: Murakami
authors.forename: Seiya
authors.initials: S
authors.lastname: Yamayoshi
authors.forename: Kiyoko
authors.initials: K
authors.lastname: Iwatsuki-Horimoto
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Sakoda
authors.forename: Emi
authors.initials: E
authors.lastname: Takashita
authors.forename: Ryan
authors.initials: R
authors.lastname: McBride
authors.forename: Takeshi
authors.initials: T
authors.lastname: Noda
authors.forename: Masato
authors.initials: M
authors.lastname: Hatta
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Imai
authors.forename: Dongming
authors.initials: D
authors.lastname: Zhao
authors.forename: Noriko
authors.initials: N
authors.lastname: Kishida
authors.forename: Masayuki
authors.initials: M
authors.lastname: Shirakura
authors.forename: Robert P
authors.initials: RP
authors.lastname: de Vries
authors.forename: Shintaro
authors.initials: S
authors.lastname: Shichinohe
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Okamatsu
authors.forename: Tomokazu
authors.initials: T
authors.lastname: Tamura
authors.forename: Yuriko
authors.initials: Y
authors.lastname: Tomita
authors.forename: Naomi
authors.initials: N
authors.lastname: Fujimoto
authors.forename: Kazue
authors.initials: K
authors.lastname: Goto
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Katsura
authors.forename: Eiryo
authors.initials: E
authors.lastname: Kawakami
authors.forename: Izumi
authors.initials: I
authors.lastname: Ishikawa
authors.forename: Shinji
authors.initials: S
authors.lastname: Watanabe
authors.forename: Mutsumi
authors.initials: M
authors.lastname: Ito
authors.forename: Yuko
authors.initials: Y
authors.lastname: Sakai-Tagawa
authors.forename: Yukihiko
authors.initials: Y
authors.lastname: Sugita
authors.forename: Ryuta
authors.initials: R
authors.lastname: Uraki
authors.forename: Reina
authors.initials: R
authors.lastname: Yamaji
authors.forename: Amie J
authors.initials: AJ
authors.lastname: Eisfeld
authors.forename: Gongxun
authors.initials: G
authors.lastname: Zhong
authors.forename: Shufang
authors.initials: S
authors.lastname: Fan
authors.forename: Jihui
authors.initials: J
authors.lastname: Ping
authors.forename: Eileen A
authors.initials: EA
authors.lastname: Maher
authors.forename: Anthony
authors.initials: A
authors.lastname: Hanson
authors.forename: Yuko
authors.initials: Y
authors.lastname: Uchida
authors.forename: Takehiko
authors.initials: T
authors.lastname: Saito
authors.forename: Makoto
authors.initials: M
authors.lastname: Ozawa
authors.forename: Gabriele
authors.initials: G
authors.lastname: Neumann
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kida
authors.forename: Takato
authors.initials: T
authors.lastname: Odagiri
authors.forename: James C
authors.initials: JC
authors.lastname: Paulson
authors.forename: Hideki
authors.initials: H
authors.lastname: Hasegawa
authors.forename: Masato
authors.initials: M
authors.lastname: Tashiro
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Kawaoka
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D002478:Cells, Cultured; D002645:Chickens / Q000821:virology; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors; D004285:Dogs; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D005289:Ferrets / Q000821:virology; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects / Q000201:enzymology; D009980:Influenza A virus / Q000737:chemistry / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity; D007251:Influenza, Human / Q000188:drug therapy / Q000821:virology*; D008252:Macaca fascicularis / Q000821:virology; D061985:Madin Darby Canine Kidney Cells; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008958:Models, Molecular; D008992:Monkey Diseases / Q000473:pathology / Q000821:virology; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D009976:Orthomyxoviridae Infections / Q000473:pathology / Q000635:transmission / Q000821:virology*; D011784:Quail / Q000821:virology; D013552:Swine / Q000821:virology; D013556:Swine, Miniature / Q000821:virology; D014779:Virus Replication / Q000187:drug effects
chemical_list: D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D012321:DNA-Directed RNA Polymerases; D009439:Neuraminidase